Home » Stocks » MBOT

Microbot Medical Inc. (MBOT)

Stock Price: $8.23 USD -0.34 (-3.97%)
Updated Feb 26, 2021 4:00 PM EST - Market closed
Market Cap 60.42M
Revenue (ttm) n/a
Net Income (ttm) -8.40M
Shares Out 7.11M
EPS (ttm) -1.31
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day February 26
Last Price $8.23
Previous Close $8.57
Change ($) -0.34
Change (%) -3.97%
Day's Open 8.51
Day's Range 8.08 - 8.55
Day's Volume 234,376
52-Week Range 4.30 - 12.20

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
GlobeNewsWire - 1 month ago

Scientific Advisory Board Expanded with Additions of Global Medical Pioneers and Distinguished Thought Leaders Scientific Advisory Board Expanded with Additions of Global Medical Pioneers and ...

GlobeNewsWire - 1 month ago

Results Validate Findings of Initial Study; End Points Achieved with No Intraoperative Adverse Events

GlobeNewsWire - 1 month ago

HINGHAM, Mass., Jan. 07, 2021 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), announced that Harel Gadot, CEO, President and Chief Executive Officer, will be presenting virtually at ...

GlobeNewsWire - 3 months ago

HINGHAM, Mass., Nov. 17, 2020 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) announced that it has received patents in multiple jurisdictions, further demonstrating the Company's con...

GlobeNewsWire - 3 months ago

Webcast to be Held on Thursday November 12 th at 2:00pm ET

GlobeNewsWire - 4 months ago

HINGHAM, Mass., Oct. 07, 2020 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for...

GlobeNewsWire - 6 months ago

Webinar to be Held on Wednesday August 26th at 11am ET Webinar to be Held on Wednesday August 26th at 11am ET

GlobeNewsWire - 6 months ago

World’s First Fully Disposable Surgical Robot Achieved all Endpoints with No Intraoperative Adverse Events

GlobeNewsWire - 6 months ago

Results to be shared on August 17th during Needham’s Virtual Med Tech & Diagnostics Conference Results to be shared on August 17th during Needham’s Virtual Med Tech & Diagnostics Conference

GlobeNewsWire - 6 months ago

Vascular Interventions Executive Will Contribute Significantly to the Development and Commercialization of LIBERTY Robotic System Vascular Interventions Executive Will Contribute Significantly...

Seeking Alpha - 8 months ago

Microbot: Miniature Medical Device Company Can Be Successful

GlobeNewsWire - 10 months ago

Proven Track Record of Numerous M&A and Strategic Collaboration Transactions Proven Track Record of Numerous M&A and Strategic Collaboration Transactions

GlobeNewsWire - 11 months ago

HINGHAM, Mass., March 03, 2020 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Microbot Medical Inc. (NASDAQ: MBOT), please note that in the first paragraph ...

GlobeNewsWire - 11 months ago

HINGHAM, Mass., March 03, 2020 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (NASDAQ: MBOT), announced the appointment of Eyal Morag, M.D., a leading radiologist, to Chief Medical Officer, effec...

Zacks Investment Research - 1 year ago

As of late, it has definitely been a great time to be an investor Microbot Medical.

Zacks Investment Research - 1 year ago

Multibagger stocks can make most of the bull run, courtesy of strong fundamentals and businesses that can multiply in a short span of time.

Other stocks mentioned: AGRX, AIRI, DERM, SAVA
GlobeNewsWire - 1 year ago

HINGHAM, Mass., Jan. 08, 2020 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) has received an official communication from the European Patent Office (EPO) regarding its intention to...

GlobeNewsWire - 1 year ago

HINGHAM, Mass., Dec. 31, 2019 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT ) closed its previously announced registered direct offering of 900,901 shares of its common stock at ...

GlobeNewsWire - 1 year ago

HINGHAM, Mass., Dec. 30, 2019 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), a medical device company specializing in the design and development of transformational micro-robotic ...

Market Watch - 1 year ago

Microbot Medical Inc. shares slid 24% Friday, after the medical device company announced a $10 million registered direct offering priced at-the-market at $10.50, a discount to its closing pri...

GlobeNewsWire - 1 year ago

HINGHAM, Mass., Dec. 27, 2019 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), a medical device company specializing in the design and development of transformational micro-robotic ...

GlobeNewsWire - 1 year ago

HINGHAM, Mass., Dec. 27, 2019 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq:MBOT) closed its previously announced registered direct offering of 912,858 shares of its common stock at a pu...

GlobeNewsWire - 1 year ago

HINGHAM, Mass., Dec. 26, 2019 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), a medical device company specializing in the design and development of transformational micro-robotic ...

24/7 Wall Street - 1 year ago

Microbot Medical Inc. (NASDAQ: MBOT) shares made a massive gain on Tuesday after the company revealed its Liberty system, which would be the world’s first fully disposable robotic system for u...

GlobeNewsWire - 1 year ago

HINGHAM, Mass., Dec. 23, 2019 (GLOBE NEWSWIRE) --  Microbot Medical Inc. (NASDAQ: MBOT) today announced the revealing of LIBERTYTM, the world’s first fully disposable robotic system for use ...

GlobeNewsWire - 1 year ago

HINGHAM, Mass., Oct. 30, 2019 (GLOBE NEWSWIRE) -- In an expansion of its significant global patent estate, Microbot Medical Inc. (Nasdaq: MBOT) announced that the U.S. Patent and Trademark O...

GlobeNewsWire - 1 year ago

Maintains Regulatory Pre-Submission Timeline of the Self-Cleaning Shunt (SCS TM )

GlobeNewsWire - 1 year ago

HINGHAM, Mass., Sept. 05, 2019 (GLOBE NEWSWIRE) -- At the upcoming Rodman & Renshaw Global Investment Conference, Harel Gadot, CEO, President and Chairman of Microbot Medical Inc. (Nasdaq: M...

About MBOT

Microbot Medical, a pre-clinical medical device company, researches, designs, and develops micro-robotics assisted medical technologies targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, and Liberty micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; a disposable self-propelled locomotive device to treat capabilities within tubular lumens, such as the blood vessels, respiratory, and the urinary and GI tracts; a combination of a guid... [Read more...]

Industry
Medical Instruments & Supplies
Founded
2010
CEO
Harel Gadot
Employees
10
Stock Exchange
NASDAQ
Ticker Symbol
MBOT
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecasts

According to one analyst, the rating for MBOT stock is "Buy" and the 12-month stock price forecast is 20.00.

Price Target
$20.00
Analyst Consensus: Buy